Patents Assigned to Janssen Pharmacetica N.V.
  • Patent number: 8680122
    Abstract: The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating glucokinase mediated disorders. More particularly, the compounds of the present invention are glucokinase modulators useful for treating disorders including, but not limited to, type II diabetes.
    Type: Grant
    Filed: October 30, 2006
    Date of Patent: March 25, 2014
    Assignee: Janssen Pharmacetica N.V.
    Inventors: Maud Urbanski, Amy Xiang, Roxanne Zeck